human recombinant erythropoietin alfa (PEGylated) (The Center of Molecular Immunology/Center for Genetic Engineering and Biotechnology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman recombinant erythropoietin alfa (PEGylated) (The Center of Molecular Immunology/Center for Genetic Engineering and Biotechnology)
Drug Alias Namehu-r-EPO (PEGylated) (The Center of Molecular Immunology/Center for Genetic Engineering and Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCuba
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter Of Molecular ImmunologyCenter For Genetic Engineering And Biotechnology
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A